AKT1 and neoplasm: Alterations of the Phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) pathway are present in many types of human tumors, regulating both the proliferation and cell survival of tumor cells and the response to anti-tumor treatment [140].